Choosing a prescription weight-loss treatment can feel personal, especially when you have already put real effort into eating differently and being more active. If you are weighing up Wegovy or Mounjaro for weight loss, the most useful question is not simply which medicine produces the biggest average result. It is which option is safe, appropriate and realistic for you to continue with alongside lasting changes to your routine.
Both treatments can reduce appetite and support meaningful weight loss when prescribed as part of a wider plan. They are not quick fixes, and neither is right for everyone. A clinician should review your health history, current medicines and weight-management goals before treatment begins.
Wegovy or Mounjaro for weight loss: the key difference
Wegovy contains semaglutide. Mounjaro contains tirzepatide. Both are once-weekly injections and both work partly by helping you feel fuller for longer, reducing hunger and slowing the rate at which food leaves the stomach.
Wegovy mimics one naturally occurring gut hormone called GLP-1. Mounjaro acts on GLP-1 as well as a second hormone receptor, GIP. This dual action may contribute to its effects on appetite, blood sugar regulation and body weight.
For many people, the practical experience is similar: you use a small weekly injection, build the dose gradually and combine treatment with nutritional, activity and behavioural support. The differences become more relevant when considering expected weight loss, side effects, medical history and what you can manage consistently.
Which treatment leads to more weight loss?
Clinical trials show that both medicines can be effective for adults living with obesity or overweight alongside weight-related health concerns. In studies of people without diabetes, participants taking Wegovy alongside lifestyle support lost an average of around 15% of their starting body weight over 68 weeks. In a separate study, people taking Mounjaro lost up to around 20% over 72 weeks, depending on dose.
A head-to-head study has also found greater average weight loss with tirzepatide than semaglutide at the doses studied. However, averages do not predict an individual outcome. Trial participants are closely supported, doses are carefully increased, and results vary according to starting weight, dose tolerance, other health conditions and whether treatment can be continued.
The medicine with the highest average figure is not automatically the best starting point. Someone who tolerates Wegovy well, can take it consistently and makes sustainable changes may see better real-world progress than someone who stops Mounjaro early because the side effects are too difficult.
Your starting point matters more than a target number
Weight loss is often measured as a percentage of your initial body weight, but health gains can happen before a dramatic change on the scales. Losing 5% to 10% of body weight may improve blood pressure, mobility, sleep, energy levels and some weight-related health risks.
Your clinician may also consider waist measurement, blood sugar, cholesterol, eating patterns and how your weight affects day-to-day life. A treatment plan should be about improving health and confidence, not chasing a single number.
Side effects: similar, but still individual
The most common side effects of Wegovy and Mounjaro are gastrointestinal. Nausea, vomiting, diarrhoea, constipation, indigestion, stomach discomfort and reduced appetite can occur, particularly after starting treatment or increasing the dose.
These effects are often temporary and may be eased by eating smaller meals, eating slowly, avoiding rich foods when symptoms are present and staying well hydrated. Dose increases are deliberately gradual to give your body time to adjust. If side effects are persistent or affecting your ability to eat or drink properly, speak to the clinical team rather than pushing through alone.
Both treatments can occasionally cause more serious problems. Seek urgent medical advice for severe, ongoing abdominal pain, especially if it spreads to the back or comes with vomiting, as this may need prompt assessment. Gallbladder problems can also occur during weight loss. Tell your prescriber about any history of pancreatitis, gallstones, severe digestive disease or diabetic eye disease.
Neither medicine should be used during pregnancy or while trying to conceive. They are also not suitable for everyone with certain personal or family histories of specific thyroid cancers. This is why an honest online consultation and clinician review matter.
How dosing and routine compare
Both Wegovy and Mounjaro are taken once a week on the same day each week. The injection is given under the skin, usually in the abdomen, thigh or upper arm. The needle is small, and most people find the process becomes straightforward with clear instructions and a little practice.
Wegovy is increased through several doses until the maintenance dose is reached. Mounjaro also starts at a low dose and is stepped up at intervals when appropriate. You may not need to progress to the highest dose if you are getting a good response or if side effects limit an increase.
It is worth thinking honestly about routine. Choose a day that works around work, childcare or travel, and set a reminder. Treatment works best when it fits into real life rather than becoming another source of pressure.
Who may be better suited to Wegovy?
Wegovy may be a sensible option if semaglutide is clinically appropriate for you, you have used it successfully before, or your prescriber believes its treatment profile best fits your medical history. It may also suit people who prefer to begin with a medicine that has been widely used in weight management for several years.
There is no prize for choosing the strongest-looking option on paper. The right prescription is one that is safe, tolerable and supported by regular review.
Who may be better suited to Mounjaro?
Mounjaro may be considered when a clinician believes tirzepatide is suitable and its potential for greater average weight loss is relevant to your goals and health needs. It can be particularly worth discussing if you have previously tried a GLP-1 treatment with limited results, although changing treatment should always be clinician-led.
Mounjaro is also used in type 2 diabetes care, but weight-management prescribing remains individual. If you take insulin, sulphonylureas or other medicines that affect blood glucose, you need careful clinical oversight because your treatment plan may need adjusting.
The part medication cannot do on its own
Wegovy and Mounjaro make appetite management easier for many people, but they do not replace nourishment, movement, sleep or support. In fact, reduced appetite makes food quality more important. Aim for regular meals containing protein, fibre and a variety of nutrients, rather than skipping meals until you are overly hungry or relying on very small amounts of food.
Resistance training or other strength-based movement can help protect muscle mass during weight loss. Walking, swimming and activities you genuinely enjoy all count too. The most effective plan is usually the least dramatic one you can repeat on an ordinary Tuesday.
Weight can return after stopping treatment, particularly if appetite returns before new habits feel established. This does not mean the medicine has failed. It means obesity is a long-term health condition for many people, and decisions about continuing, changing or stopping treatment should be made with clinical support.
Choosing safely through an online pharmacy
A trustworthy online service should do more than dispatch a pen. It should ask appropriate medical questions, provide clinician review, supply licensed treatment from a regulated UK pharmacy and make it clear how to get help with side effects, dose queries or refills.
At Online UK Pharmacy, weight-management treatment begins with a structured assessment reviewed by UK-based clinicians, not an automated chatbot. Once approved, treatment is dispensed directly and sent in discreet plain packaging, with ongoing support from the same clinical team where possible.
Be cautious about websites that promise guaranteed results, offer prescription medicines without meaningful health checks, or make it difficult to identify the pharmacy and prescriber. Your safety should never be an optional extra for the sake of speed.
The best next step is a clinician-led conversation about your health, your previous attempts at weight loss and the support you need to keep going. Whether Wegovy or Mounjaro is suitable, a plan that feels personal, safe and manageable gives you something far more valuable than a short-term result: a realistic way forward.
